Policy & Regulation
French pharma industries champion clear drug information measures
15 January 2013 - 15 January 2013 - The French federation of pharmaceutical companies Leem acknowledged yesterday the reply of healthcare minister Marisol Touraine on the concerns linked to third- and...
French competition watchdog makes pharma sector priority in 2013 - report
15 January 2013 - 15 January 2013 - The French competition watchdog has identified as a priority for 2013 conducting a study of the situation in the country’s pharmaceutical industry, the regula...
EMA confirms marketing authorisation for 3rd, 4th-generation pills
14 January 2013 - 14 January 2013 - The European Medicines Agency (EMA) reiterated on Friday the marketing authorisation for third- and fourth-generation contraceptive pills, since there was no new pr...
Telik Incorporated notifies FDA orphan drug designation to ezatiostat HCL
14 January 2013 - Telik Incorporated (Nasdaq: TELK), a biopharmaceutical company, has announced today that it has notified FDA orphan drug designation to ezatiostat HCL (Telintra). The drug designati...
NRC licenses use of radium-223 to treat prostate cancer
14 January 2013 - 14 January 2013 - Norwegian Algeta ASA (OSL:ALGETA) said today the US Nuclear Regulatory Commission (NRC) had authorised the use of radium-223 dichloride (radium-223) after the prost...
FDA demands lowering of recommended dose for certain zolpidem-containing insomnia drugs
11 January 2013 - 11 January 2013 - The US Food and Drug Administration (FDA) has required that the manufacturers of certain sleep drugs containing the active ingredient zolpidem should lower the reco...